Tata Nageswara Rao

In vivo fate mapping identifies pre-TCRα expression as an intra- and extrathymic, but not prethymic, marker of T lymphopoiesis

H. Fehling, C. Blum, H. Rodewald, 2013, The Journal of experimental medicine.

Remodeling of metabolism and inflammation by exercise ameliorates tumor-associated anemia

R. Skoda, C. Handschin, R. Furrer, 2021, Science advances.

JAK2 mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms.

M. Gassmann, A. Lane, N. Kröger, 2019, Blood.

Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.

T. Schroeder, T. Ganz, J. Passweg, 2023, Blood.